Ryxel

healthcare News

Tharimmune Stock Surges Over 200% on Opioid Countermeasure Data
Healthcare
5mo ago

Tharimmune Stock Surges Over 200% on Opioid Countermeasure Data

Positive FDA feedback and promising 24-hour protection data for its fentanyl overdose prophylactic, TH104, fuel the rally.

Iovance Soars as Melanoma Drug Gains First International Approval
Healthcare
5mo ago

Iovance Soars as Melanoma Drug Gains First International Approval

Health Canada's conditional nod for Amtagvi opens new markets for the cell therapy, following its earlier US FDA approval.

Viking Therapeutics Plummets 43% Despite Positive Obesity Drug Data
Healthcare
5mo ago

Viking Therapeutics Plummets 43% Despite Positive Obesity Drug Data

Impressive Phase 2 trial results for its oral weight-loss pill were not enough to satisfy high investor expectations, triggering a massive sell-off.